Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis

Published:2022-11 Issue: Volume:110 Page:102464
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Volpe Stefania,Piperno Gaia,Colombo Francesca,Biffi Annalisa,Comi Stefania,Mastroleo Federico,Maria Camarda Anna,Casbarra Alessia,Cattani Federica,Corrao Giulia,de Marinis Filippo,Spaggiari Lorenzo,Guckenberger Matthias,Orecchia Roberto,Alterio Daniela,Jereczek-Fossa Barbara Alicja

Funder

Ministero della Salute

International Association for Bear Research and Management

Accuray

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference78 articles.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 2021; caac.21660.

2. Refining the treatment of NSCLC according to histological and molecular subtypes;Thomas;Nat Rev Clin Oncol,2015

3. A narrative review of invasive diagnostics and treatment of early lung cancer;Dziedzic;Transl Lung Cancer Res,2021

4. NCCN- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)- Non-Small Cell Lung Cancer. Version 4.2021- March 3, 2021, https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

5. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer;Guckenberger;Radiother Oncol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial;eClinicalMedicine;2024-09

2. Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113–08113 LungTech Phase II Trial Results;Journal of Thoracic Oncology;2024-09

3. Facing the climate change: is radiotherapy as green as we would like? A systematic review;Critical Reviews in Oncology/Hematology;2024-09

4. Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study;Radiotherapy and Oncology;2024-07

5. A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry;BMC Cancer;2024-03-12